Public procurement notice: Additional Information
Published: 2016-02-03
Buyer: Commercial Medicines Unit
Country: UK
Region: NORTH EAST (ENGLAND)
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33600000: Pharmaceutical products | 33690000
Submission deadline: 2016-02-16
Award criteria: The most economic tender

Technical requirements: Following the consultation with suppliers on the 21.12.2015, relating to the scope of the patents in force for the products listed within this tender, the attached document (Document No.06a(i) Product listing and usage January 2016) lists those products that are now being taken forward. The 3 products detailed below have now been removed from the tender.
Budesonide/FormoteroL (Symbicort Turbohaler) — see ITT attachment Document No. 06 — Offer Schedule Budesonide/Formoterol (Symbicort or EQ) for completion and return if you are apply to supply.
Additionally this has further impacted the tender timetable and framework start date and end dates. The revised timescales are shown below:
If you have already uploaded the original SELECTT offer schedule CM/PHG//12/5338/00 please remove this from Bravo. To make an offer for the remaining products detailed on the attached Document No.06a(i) Product listing and usage, please submit your offer within the new SELECTT offer Document No.06a(ii) SELECTT offer schedule — CM/PHG/12/5338/01. The changes made to this SELECTT offer schedule are to the framework start and end dates and some products have been removed, as detailed above. No awards will be made for those products removed and any offers received for those products, using the previous SELECTT file CM/PHG//12/5338/00 will not be considered at adjudication.
A separate offer schedule for the product LINEZOLID 600MG Tablets was originally issued Document No.06 Offer Schedule Linezolid 600 mg tablets, this product now features within the new SELECTT offer schedule, therefore you can submit your entire offer using the SELECTT file.
Following the consultation with suppliers on the 21.12.2015, relating to the scope of the patents in force for the products listed within this tender, the attached document (Document No.06a(i) Product listing and usage January 2016) lists those products that are now being taken forward. The 3 products detailed below have now been removed from the tender.
Budesonide/FormoteroL (Symbicort Turbohaler) — see ITT attachment Document No. 06 — Offer Schedule Budesonide/Formoterol (Symbicort or EQ) for completion and return if you are apply to supply.
Additionally this has further impacted the tender timetable and framework start date and end dates. The revised timescales are shown below:
If you have already uploaded the original SELECTT offer schedule CM/PHG//12/5338/00 please remove this from Bravo. To make an offer for the remaining products detailed on the attached Document No.06a(i) Product listing and usage, please submit your offer within the new SELECTT offer Document No.06a(ii) SELECTT offer schedule — CM/PHG/12/5338/01. The changes made to this SELECTT offer schedule are to the framework start and end dates and some products have been removed, as detailed above. No awards will be made for those products removed and any offers received for those products, using the previous SELECTT file CM/PHG//12/5338/00 will not be considered at adjudication.
A separate offer schedule for the product LINEZOLID 600MG Tablets was originally issued Document No.06 Offer Schedule Linezolid 600 mg tablets, this product now features within the new SELECTT offer schedule, therefore you can submit your entire offer using the SELECTT file.
Following the consultation with suppliers on the 21.12.2015, relating to the scope of the patents in force for the products listed within this tender, the attached document (Document No.06a(i) Product listing and usage January 2016) lists those products that are now being taken forward. The 3 products detailed below have now been removed from the tender.
Budesonide/FormoteroL (Symbicort Turbohaler) — see ITT attachment Document No. 06 — Offer Schedule Budesonide/Formoterol (Symbicort or EQ) for completion and return if you are apply to supply.
Additionally this has further impacted the tender timetable and framework start date and end dates. The revised timescales are shown below:
If you have already uploaded the original SELECTT offer schedule CM/PHG//12/5338/00 please remove this from Bravo. To make an offer for the remaining products detailed on the attached Document No.06a(i) Product listing and usage, please submit your offer within the new SELECTT offer Document No.06a(ii) SELECTT offer schedule — CM/PHG/12/5338/01. The changes made to this SELECTT offer schedule are to the framework start and end dates and some products have been removed, as detailed above. No awards will be made for those products removed and any offers received for those products, using the previous SELECTT file CM/PHG//12/5338/00 will not be considered at adjudication.
A separate offer schedule for the product LINEZOLID 600MG Tablets was originally issued Document No.06 Offer Schedule Linezolid 600 mg tablets, this product now features within the new SELECTT offer schedule, therefore you can submit your entire offer using the SELECTT file.